NYSE · EL
The Estée Lauder Companies Inc.
$108.81-$0.50 (-0.46%)
The Estée Lauder Companies Inc.’s quoted price sits in the upper half of its reported 52-week range, 10.55% below the high.
Loading market information…
NYSE · HIMS · USD
Stock price, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Hims & Hers Health, Inc.’s quoted price sits in the lower half of its reported 52-week range, 38.62% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Hims & Hers Health, Inc.’s next earnings report is currently expected on Nov 9, 2026, with estimated earnings per share of $0.06. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Hims & Hers Health, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Hims & Hers Health, Inc. operates a comprehensive digital health platform that seamlessly links individuals with licensed medical professionals for virtual consultations and ongoing care. Through its user-friendly websites and mobile app, the company delivers a diverse portfolio of health and wellness solutions directly to consumers. This includes access to recurring prescription medications, alongside a wide selection of over-the-counter drugs, devices, cosmetics, and dietary supplements. Its core focus areas are general wellness, sexual health, skincare, and hair care. Specific non-prescription offerings span categories such as: Wellness: encompassing items like vitamin C, melatonin, biotin, and collagen protein supplements. Skincare: including products such as moisturizers, serums, and face washes. Sexual Health: providing essentials like condoms, climax delay sprays and wipes, vibrators, and lubricants. Hair Care: offering specialized shampoos, conditioners, scalp scrubs, and topical treatments like minoxidil. Beyond direct sales, Hims & Hers also distributes health and wellness products via wholesale partnerships. The company's headquarters are located in San Francisco, California.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 02:32 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q1 2025 | May 5, 2025 | $0.20+65.43% vs estimate | $586.01M+8.8% vs estimate |
|---|
| Q4 2024 | Feb 24, 2025 | $0.11+22.22% vs estimate | $481.14M-2.71% vs estimate |
|---|
| Q3 2024 | Nov 4, 2024 | $0.32+433.33% vs estimate | $401.56M+5.07% vs estimate |
|---|
THE ANALYST VIEW
20 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
Percentages compare targets with the quoted price when currencies match. Targets are analyst estimates, not guaranteed outcomes.
Consensus coverage: 9 contributors · Median target $32.00.
Average targets in published notes for each window. These figures use a different sample from the consensus above.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$108.81-$0.50 (-0.46%)
The Estée Lauder Companies Inc.’s quoted price sits in the upper half of its reported 52-week range, 10.55% below the high.
$19.56+$0.23 (+1.19%)
Kenvue Inc.’s quoted price sits in the upper half of its reported 52-week range, 2.83% below the high.
$112.95-$2.46 (-2.13%)
e.l.f. Beauty, Inc.’s quoted price sits in the upper half of its reported 52-week range, 10.54% below the high.
$3.35-$0.01 (-0.3%)
Coty Inc.’s quoted price sits in the upper half of its reported 52-week range, 19.47% below the high.
$15.90-$0.02 (-0.13%)
Perrigo Company plc’s quoted price sits in the upper half of its reported 52-week range, 25.46% below the high.
$28.57+$0.90 (+3.25%)
Edgewell Personal Care Company’s quoted price sits in the upper half of its reported 52-week range, 4.61% below the high.
$29.71+$0.40 (+1.36%)
Helen of Troy Limited’s quoted price sits in the upper half of its reported 52-week range, 7.1% below the high.
$4.59+$0.02 (+0.44%)
The Honest Company, Inc.’s quoted price sits in the upper half of its reported 52-week range, 23.63% below the high.
